Clinical Trials Sponsored by Northside Hospital, Inc.

Total 20 results

  • NCT04408040
    Recruiting
    Conditions: COVID
  • NCT04237623
    Recruiting
    Conditions: Transplant-Related Hematologic Malignancy
  • NCT04235036
    Recruiting
    Conditions: Graft Vs Host Disease
  • NCT02771197
    Recruiting
    Conditions: Acute Myeloid Leukemia
  • NCT02828592
    Recruiting
    Conditions: Severe Aplastic Anemia
  • NCT02416206
    Active, not recruiting
    Conditions: Multiple Myeloma
  • NCT02581007
    Completed
    Conditions: Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Myelofibrosis, CMML, Multiple Myeloma
  • NCT02169791
    Active, not recruiting
    Conditions: Acute Leukemia, Chronic Leukemia, Myelodysplastic Syndrome, Lymphomas, Multiple Myeloma
  • NCT01084694
    Completed
    Conditions: Depression, Anxiety, Fatigue, Distress
  • NCT02101463
    Terminated
    Conditions: Complex Aortic Aneurysms
  • NCT01097928
    Recruiting
    Conditions: Pulmonary Embolism
  • NCT01328873
    Completed
    Conditions: Pulmonary Infiltrate New
  • NCT01370408
    Completed
    Conditions: Chemotherapy-induced Nausea and Vomiting
  • NCT01161628
    Completed
    Conditions: Chronic Graft-versus-host Disease
  • NCT01336712
    Completed
    Conditions: Chronic Leukemia, Acute Leukemia, Hodgkin's Disease, Non-Hodgkin's Lymphoma, Myelodysplastic Syndrome
  • NCT01244906
    Completed
    Conditions: Hematologic Neoplasms
  • NCT00818961
    Terminated
    Conditions: Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
  • NCT00782379
    Completed
    Conditions: Leukemia, Lymphoma, Myelodysplastic Syndromes
  • NCT00787761
    Completed
    Conditions: Myeloproliferative Disorders, Kidney Cancer, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
  • NCT00827099
    Terminated
    Conditions: Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes